Conflicting results between the analysis of skin lesions using a mobile-phone application and a dermatologist's clinical diagnosis: a pilot study.

https://www.ncbi.nlm.nih.gov/pubmed/28295172

Br J Dermatol. 2017 Mar 10. doi: 10.1111/bjd.15443. [Epub ahead of print] Poor agreement between a mobile phone application for the analysis of skin lesions and the clinical diagnosis of the dermatologist, a pilot study. Nabil R1, Bergman W1, Kukutsch NA1. Author information: 1 Department of Dermatology, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, The Netherlands. Abstract The use of mobile phone health applications (apps) has become very popular in the population. The SkinVision app (SVA) is the first skin cancer app with an European CE-certification.1 This means that a product has met EU health, safety and environmental requirements.2 SkinVision lets the consumer "take photos of moles and skin conditions to analyse for skin cancer risk".1 Artificial intelligence is used to automatically interpret the modified image. Based on this analysis, it evaluates lesions as low (green), medium (yellow) or high risk (red).1 This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.

PMID: 28295172

PDF(-)